期刊
MICROBIAL CELL FACTORIES
卷 11, 期 -, 页码 -出版社
BMC
DOI: 10.1186/1475-2859-11-155
关键词
Saccharomyces cerevisiae; Naringenin; de novo; Flavonoids; Metabolic engineering
资金
- The Netherlands Genomics Initiative
- Platform Green Synthetic Biology programme
- NGI
- NGI through the Horizon breakthrough programme [93519011]
- EU 7th Framework ATHENA project [FP7-KBBE-2009-3-245121-ATHENA]
- BIOFLAVOUR, COST Action [FA0907]
Background: Flavonoids comprise a large family of secondary plant metabolic intermediates that exhibit a wide variety of antioxidant and human health-related properties. Plant production of flavonoids is limited by the low productivity and the complexity of the recovered flavonoids. Thus to overcome these limitations, metabolic engineering of specific pathway in microbial systems have been envisaged to produce high quantity of a single molecules. Result: Saccharomyces cerevisiae was engineered to produce the key intermediate flavonoid, naringenin, solely from glucose. For this, specific naringenin biosynthesis genes from Arabidopsis thaliana were selected by comparative expression profiling and introduced in S. cerevisiae. The sole expression of these A. thaliana genes yielded low extracellular naringenin concentrations (<5.5 mu M). To optimize naringenin titers, a yeast chassis strain was developed. Synthesis of aromatic amino acids was deregulated by alleviating feedback inhibition of 3-deoxy-d-arabinose-heptulosonate-7-phosphate synthase (Aro3, Aro4) and byproduct formation was reduced by eliminating phenylpyruvate decarboxylase (Aro10, Pdc5, Pdc6). Together with an increased copy number of the chalcone synthase gene and expression of a heterologous tyrosine ammonia lyase, these modifications resulted in a 40 fold increase of extracellular naringenin titers (to approximately 200 mu M) in glucose-grown shake flask cultures. In aerated, pH controlled batch reactors, extracellular naringenin concentrations of over 400 mu M were reached. Conclusion: The results reported in this study demonstrate that S. cerevisiae is capable of de novo production of naringenin by coexpressing the naringenin production genes from A. thaliana and optimization of the flux towards the naringenin pathway. The engineered yeast naringenin production host provides a metabolic chassis for production of a wide range of flavonoids and exploration of their biological functions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据